 | • レポートコード：QYR2104Z5845 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、133ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、子宮筋腫のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（非ホルモン療法、ホルモン療法）、用途別市場規模（病院、外来手術センター、診断センター、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・子宮筋腫の市場動向 ・企業の競争状況、市場シェア ・子宮筋腫の種類別市場規模（非ホルモン療法、ホルモン療法） ・子宮筋腫の用途別市場規模（病院、外来手術センター、診断センター、その他） ・子宮筋腫の北米市場規模2016-2027（アメリカ、カナダ） ・子宮筋腫のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・子宮筋腫のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・子宮筋腫の中南米市場規模2016-2027（メキシコ、ブラジル） ・子宮筋腫の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Boston Scientific、Cooper Surgical、C.R. Bard、F. Hoffmann-La Roche、GE Healthcare、Karl Storz Endoscopy、Richard Wolf Medical Instruments、Siemens Medical Solutions、AbbVie、AstraZeneca、Bayer、Eli Lilly、GlaxoSmithKline Pharmaceuticals、Pfizer、Johnson & Johnson、Novartis） ・結論 |
Uterine fibroids (myoma) are benign (non-cancerous) lumps that grow in the muscular wall of the uterus. They vary in sizes, from minute (a quarter of an inch) to the size of more than16 centimeters. The incidence of uterine fibroid is about 20%–40% in women during their reproductive ages. Occasionally, these fibroids swell up and make the uterus to grow like full visible pregnancy. Mostly, there are more than one fibroid in the uterus. However, fibroids do not always cause any symptoms, their location, and size results to difficulties for few women, including pain, discomfort and heavy bleeding. Uterine fibroid can be of different types such as intramural fibroids, subserosal fibroids, pedunculated fibroids and submucosal fibroids. There can be many reasons for uterine fibroid formation but genetic problems hormonal imbalance and other factors are predominant. The cardinal symptoms of uterine fibroids are heavy menstrual bleeding, abdominal pain, excessive uterine bleeding, increased urinary frequency, anaemia and infertility. Apart from physical morbidity, uterine fibroid ailment is a frequent cause of significant damage of quality of life and a major reason for hysterectomy. Therapy has traditionally based on two extremes: medicinal management, comprising progestins, oral contraceptives and GnRH agonists and surgical management, including myomectomy, hysterectomy, and ablation for most serious cases.
Patients suffering from uterine fibroid problem represent an undeserved and huge market due to the absence of satisfactory medical treatments. Uterine fibroids affects nearly 40% of women in the age group of 30 and 55, including 20 million women in North America and 24 million women in Europe with over 7 million patients worldwide presently undergo various symptom management treatments.
Market Analysis and Insights: Global Uterine Fibroids Market
The global Uterine Fibroids market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Uterine Fibroids market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Uterine Fibroids market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Uterine Fibroids market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Uterine Fibroids market.
Global Uterine Fibroids Scope and Market Size
Uterine Fibroids market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Uterine Fibroids market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Non-Hormonal Treatment
Hormonal Treatment
Segment by Application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Boston Scientific
Cooper Surgical
C.R. Bard
F. Hoffmann-La Roche
GE Healthcare
Karl Storz Endoscopy
Richard Wolf Medical Instruments
Siemens Medical Solutions
AbbVie
F. Hoffmann-La Roche
GE Healthcare
Eli Lilly
GlaxoSmithKline Pharmaceuticals
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Uterine Fibroids Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Non-Hormonal Treatment
1.2.3 Hormonal Treatment
1.3 Market by Application
1.3.1 Global Uterine Fibroids Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Diagnostic Centers
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Uterine Fibroids Market Perspective (2016-2027)
2.2 Uterine Fibroids Growth Trends by Regions
2.2.1 Uterine Fibroids Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Uterine Fibroids Historic Market Share by Regions (2016-2021)
2.2.3 Uterine Fibroids Forecasted Market Size by Regions (2022-2027)
2.3 Uterine Fibroids Industry Dynamic
2.3.1 Uterine Fibroids Market Trends
2.3.2 Uterine Fibroids Market Drivers
2.3.3 Uterine Fibroids Market Challenges
2.3.4 Uterine Fibroids Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Uterine Fibroids Players by Revenue
3.1.1 Global Top Uterine Fibroids Players by Revenue (2016-2021)
3.1.2 Global Uterine Fibroids Revenue Market Share by Players (2016-2021)
3.2 Global Uterine Fibroids Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Uterine Fibroids Revenue
3.4 Global Uterine Fibroids Market Concentration Ratio
3.4.1 Global Uterine Fibroids Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Uterine Fibroids Revenue in 2020
3.5 Uterine Fibroids Key Players Head office and Area Served
3.6 Key Players Uterine Fibroids Product Solution and Service
3.7 Date of Enter into Uterine Fibroids Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Uterine Fibroids Breakdown Data by Type
4.1 Global Uterine Fibroids Historic Market Size by Type (2016-2021)
4.2 Global Uterine Fibroids Forecasted Market Size by Type (2022-2027)
5 Uterine Fibroids Breakdown Data by Application
5.1 Global Uterine Fibroids Historic Market Size by Application (2016-2021)
5.2 Global Uterine Fibroids Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Uterine Fibroids Market Size (2016-2027)
6.2 North America Uterine Fibroids Market Size by Type
6.2.1 North America Uterine Fibroids Market Size by Type (2016-2021)
6.2.2 North America Uterine Fibroids Market Size by Type (2022-2027)
6.2.3 North America Uterine Fibroids Market Size by Type (2016-2027)
6.3 North America Uterine Fibroids Market Size by Application
6.3.1 North America Uterine Fibroids Market Size by Application (2016-2021)
6.3.2 North America Uterine Fibroids Market Size by Application (2022-2027)
6.3.3 North America Uterine Fibroids Market Size by Application (2016-2027)
6.4 North America Uterine Fibroids Market Size by Country
6.4.1 North America Uterine Fibroids Market Size by Country (2016-2021)
6.4.2 North America Uterine Fibroids Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Uterine Fibroids Market Size (2016-2027)
7.2 Europe Uterine Fibroids Market Size by Type
7.2.1 Europe Uterine Fibroids Market Size by Type (2016-2021)
7.2.2 Europe Uterine Fibroids Market Size by Type (2022-2027)
7.2.3 Europe Uterine Fibroids Market Size by Type (2016-2027)
7.3 Europe Uterine Fibroids Market Size by Application
7.3.1 Europe Uterine Fibroids Market Size by Application (2016-2021)
7.3.2 Europe Uterine Fibroids Market Size by Application (2022-2027)
7.3.3 Europe Uterine Fibroids Market Size by Application (2016-2027)
7.4 Europe Uterine Fibroids Market Size by Country
7.4.1 Europe Uterine Fibroids Market Size by Country (2016-2021)
7.4.2 Europe Uterine Fibroids Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Uterine Fibroids Market Size (2016-2027)
8.2 Asia-Pacific Uterine Fibroids Market Size by Type
8.2.1 Asia-Pacific Uterine Fibroids Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Uterine Fibroids Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Uterine Fibroids Market Size by Type (2016-2027)
8.3 Asia-Pacific Uterine Fibroids Market Size by Application
8.3.1 Asia-Pacific Uterine Fibroids Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Uterine Fibroids Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Uterine Fibroids Market Size by Application (2016-2027)
8.4 Asia-Pacific Uterine Fibroids Market Size by Region
8.4.1 Asia-Pacific Uterine Fibroids Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Uterine Fibroids Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Uterine Fibroids Market Size (2016-2027)
9.2 Latin America Uterine Fibroids Market Size by Type
9.2.1 Latin America Uterine Fibroids Market Size by Type (2016-2021)
9.2.2 Latin America Uterine Fibroids Market Size by Type (2022-2027)
9.2.3 Latin America Uterine Fibroids Market Size by Type (2016-2027)
9.3 Latin America Uterine Fibroids Market Size by Application
9.3.1 Latin America Uterine Fibroids Market Size by Application (2016-2021)
9.3.2 Latin America Uterine Fibroids Market Size by Application (2022-2027)
9.3.3 Latin America Uterine Fibroids Market Size by Application (2016-2027)
9.4 Latin America Uterine Fibroids Market Size by Country
9.4.1 Latin America Uterine Fibroids Market Size by Country (2016-2021)
9.4.2 Latin America Uterine Fibroids Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Uterine Fibroids Market Size (2016-2027)
10.2 Middle East & Africa Uterine Fibroids Market Size by Type
10.2.1 Middle East & Africa Uterine Fibroids Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Uterine Fibroids Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Uterine Fibroids Market Size by Type (2016-2027)
10.3 Middle East & Africa Uterine Fibroids Market Size by Application
10.3.1 Middle East & Africa Uterine Fibroids Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Uterine Fibroids Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Uterine Fibroids Market Size by Application (2016-2027)
10.4 Middle East & Africa Uterine Fibroids Market Size by Country
10.4.1 Middle East & Africa Uterine Fibroids Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Uterine Fibroids Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Boston Scientific
11.1.1 Boston Scientific Company Details
11.1.2 Boston Scientific Business Overview
11.1.3 Boston Scientific Uterine Fibroids Introduction
11.1.4 Boston Scientific Revenue in Uterine Fibroids Business (2016-2021)
11.1.5 Boston Scientific Recent Development
11.2 Cooper Surgical
11.2.1 Cooper Surgical Company Details
11.2.2 Cooper Surgical Business Overview
11.2.3 Cooper Surgical Uterine Fibroids Introduction
11.2.4 Cooper Surgical Revenue in Uterine Fibroids Business (2016-2021)
11.2.5 Cooper Surgical Recent Development
11.3 C.R. Bard
11.3.1 C.R. Bard Company Details
11.3.2 C.R. Bard Business Overview
11.3.3 C.R. Bard Uterine Fibroids Introduction
11.3.4 C.R. Bard Revenue in Uterine Fibroids Business (2016-2021)
11.3.5 C.R. Bard Recent Development
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Company Details
11.4.2 F. Hoffmann-La Roche Business Overview
11.4.3 F. Hoffmann-La Roche Uterine Fibroids Introduction
11.4.4 F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2016-2021)
11.4.5 F. Hoffmann-La Roche Recent Development
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Uterine Fibroids Introduction
11.5.4 GE Healthcare Revenue in Uterine Fibroids Business (2016-2021)
11.5.5 GE Healthcare Recent Development
11.6 Karl Storz Endoscopy
11.6.1 Karl Storz Endoscopy Company Details
11.6.2 Karl Storz Endoscopy Business Overview
11.6.3 Karl Storz Endoscopy Uterine Fibroids Introduction
11.6.4 Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2016-2021)
11.6.5 Karl Storz Endoscopy Recent Development
11.7 Richard Wolf Medical Instruments
11.7.1 Richard Wolf Medical Instruments Company Details
11.7.2 Richard Wolf Medical Instruments Business Overview
11.7.3 Richard Wolf Medical Instruments Uterine Fibroids Introduction
11.7.4 Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2016-2021)
11.7.5 Richard Wolf Medical Instruments Recent Development
11.8 Siemens Medical Solutions
11.8.1 Siemens Medical Solutions Company Details
11.8.2 Siemens Medical Solutions Business Overview
11.8.3 Siemens Medical Solutions Uterine Fibroids Introduction
11.8.4 Siemens Medical Solutions Revenue in Uterine Fibroids Business (2016-2021)
11.8.5 Siemens Medical Solutions Recent Development
11.9 AbbVie
11.9.1 AbbVie Company Details
11.9.2 AbbVie Business Overview
11.9.3 AbbVie Uterine Fibroids Introduction
11.9.4 AbbVie Revenue in Uterine Fibroids Business (2016-2021)
11.9.5 AbbVie Recent Development
11.10 AstraZeneca
11.10.1 AstraZeneca Company Details
11.10.2 AstraZeneca Business Overview
11.10.3 AstraZeneca Uterine Fibroids Introduction
11.10.4 AstraZeneca Revenue in Uterine Fibroids Business (2016-2021)
11.10.5 AstraZeneca Recent Development
11.11 Bayer
11.11.1 Bayer Company Details
11.11.2 Bayer Business Overview
11.11.3 Bayer Uterine Fibroids Introduction
11.11.4 Bayer Revenue in Uterine Fibroids Business (2016-2021)
11.11.5 Bayer Recent Development
11.12 Eli Lilly
11.12.1 Eli Lilly Company Details
11.12.2 Eli Lilly Business Overview
11.12.3 Eli Lilly Uterine Fibroids Introduction
11.12.4 Eli Lilly Revenue in Uterine Fibroids Business (2016-2021)
11.12.5 Eli Lilly Recent Development
11.13 GlaxoSmithKline Pharmaceuticals
11.13.1 GlaxoSmithKline Pharmaceuticals Company Details
11.13.2 GlaxoSmithKline Pharmaceuticals Business Overview
11.13.3 GlaxoSmithKline Pharmaceuticals Uterine Fibroids Introduction
11.13.4 GlaxoSmithKline Pharmaceuticals Revenue in Uterine Fibroids Business (2016-2021)
11.13.5 GlaxoSmithKline Pharmaceuticals Recent Development
11.14 Pfizer
11.14.1 Pfizer Company Details
11.14.2 Pfizer Business Overview
11.14.3 Pfizer Uterine Fibroids Introduction
11.14.4 Pfizer Revenue in Uterine Fibroids Business (2016-2021)
11.14.5 Pfizer Recent Development
11.15 Johnson & Johnson
11.15.1 Johnson & Johnson Company Details
11.15.2 Johnson & Johnson Business Overview
11.15.3 Johnson & Johnson Uterine Fibroids Introduction
11.15.4 Johnson & Johnson Revenue in Uterine Fibroids Business (2016-2021)
11.15.5 Johnson & Johnson Recent Development
11.16 Novartis
11.16.1 Novartis Company Details
11.16.2 Novartis Business Overview
11.16.3 Novartis Uterine Fibroids Introduction
11.16.4 Novartis Revenue in Uterine Fibroids Business (2016-2021)
11.16.5 Novartis Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Uterine Fibroids Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Non-Hormonal Treatment
Table 3. Key Players of Hormonal Treatment
Table 4. Global Uterine Fibroids Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Uterine Fibroids Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Uterine Fibroids Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Uterine Fibroids Market Share by Regions (2016-2021)
Table 8. Global Uterine Fibroids Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Uterine Fibroids Market Share by Regions (2022-2027)
Table 10. Uterine Fibroids Market Trends
Table 11. Uterine Fibroids Market Drivers
Table 12. Uterine Fibroids Market Challenges
Table 13. Uterine Fibroids Market Restraints
Table 14. Global Uterine Fibroids Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Uterine Fibroids Market Share by Players (2016-2021)
Table 16. Global Top Uterine Fibroids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroids as of 2020)
Table 17. Ranking of Global Top Uterine Fibroids Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Uterine Fibroids Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Uterine Fibroids Product Solution and Service
Table 21. Date of Enter into Uterine Fibroids Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Uterine Fibroids Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Uterine Fibroids Revenue Market Share by Type (2016-2021)
Table 25. Global Uterine Fibroids Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Uterine Fibroids Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Uterine Fibroids Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Uterine Fibroids Revenue Market Share by Application (2016-2021)
Table 29. Global Uterine Fibroids Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Uterine Fibroids Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Uterine Fibroids Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Uterine Fibroids Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Uterine Fibroids Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Uterine Fibroids Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Uterine Fibroids Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Uterine Fibroids Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Uterine Fibroids Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Uterine Fibroids Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Uterine Fibroids Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Uterine Fibroids Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Uterine Fibroids Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Uterine Fibroids Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Uterine Fibroids Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Uterine Fibroids Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Uterine Fibroids Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Uterine Fibroids Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Uterine Fibroids Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Uterine Fibroids Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Uterine Fibroids Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Uterine Fibroids Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Uterine Fibroids Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Uterine Fibroids Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Uterine Fibroids Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Uterine Fibroids Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Uterine Fibroids Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Uterine Fibroids Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Uterine Fibroids Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Uterine Fibroids Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Uterine Fibroids Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Uterine Fibroids Market Size by Country (2022-2027) & (US$ Million)
Table 61. Boston Scientific Company Details
Table 62. Boston Scientific Business Overview
Table 63. Boston Scientific Uterine Fibroids Product
Table 64. Boston Scientific Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 65. Boston Scientific Recent Development
Table 66. Cooper Surgical Company Details
Table 67. Cooper Surgical Business Overview
Table 68. Cooper Surgical Uterine Fibroids Product
Table 69. Cooper Surgical Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 70. Cooper Surgical Recent Development
Table 71. C.R. Bard Company Details
Table 72. C.R. Bard Business Overview
Table 73. C.R. Bard Uterine Fibroids Product
Table 74. C.R. Bard Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 75. C.R. Bard Recent Development
Table 76. F. Hoffmann-La Roche Company Details
Table 77. F. Hoffmann-La Roche Business Overview
Table 78. F. Hoffmann-La Roche Uterine Fibroids Product
Table 79. F. Hoffmann-La Roche Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 80. F. Hoffmann-La Roche Recent Development
Table 81. GE Healthcare Company Details
Table 82. GE Healthcare Business Overview
Table 83. GE Healthcare Uterine Fibroids Product
Table 84. GE Healthcare Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 85. GE Healthcare Recent Development
Table 86. Karl Storz Endoscopy Company Details
Table 87. Karl Storz Endoscopy Business Overview
Table 88. Karl Storz Endoscopy Uterine Fibroids Product
Table 89. Karl Storz Endoscopy Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 90. Karl Storz Endoscopy Recent Development
Table 91. Richard Wolf Medical Instruments Company Details
Table 92. Richard Wolf Medical Instruments Business Overview
Table 93. Richard Wolf Medical Instruments Uterine Fibroids Product
Table 94. Richard Wolf Medical Instruments Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 95. Richard Wolf Medical Instruments Recent Development
Table 96. Siemens Medical Solutions Company Details
Table 97. Siemens Medical Solutions Business Overview
Table 98. Siemens Medical Solutions Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 99. Siemens Medical Solutions Recent Development
Table 100. AbbVie Company Details
Table 101. AbbVie Business Overview
Table 102. AbbVie Uterine Fibroids Product
Table 103. AbbVie Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 104. AbbVie Recent Development
Table 105. AstraZeneca Company Details
Table 106. AstraZeneca Business Overview
Table 107. AstraZeneca Uterine Fibroids Product
Table 108. AstraZeneca Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 109. AstraZeneca Recent Development
Table 110. Bayer Company Details
Table 111. Bayer Business Overview
Table 112. Bayer Uterine Fibroids Product
Table 113. Bayer Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 114. Bayer Recent Development
Table 115. Eli Lilly Company Details
Table 116. Eli Lilly Business Overview
Table 117. Eli Lilly Uterine Fibroids Product
Table 118. Eli Lilly Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 119. Eli Lilly Recent Development
Table 120. GlaxoSmithKline Pharmaceuticals Company Details
Table 121. GlaxoSmithKline Pharmaceuticals Business Overview
Table 122. GlaxoSmithKline Pharmaceuticals Uterine Fibroids Product
Table 123. GlaxoSmithKline Pharmaceuticals Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 124. GlaxoSmithKline Pharmaceuticals Recent Development
Table 125. Pfizer Company Details
Table 126. Pfizer Business Overview
Table 127. Pfizer Uterine Fibroids Product
Table 128. Pfizer Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 129. Pfizer Recent Development
Table 130. Johnson & Johnson Company Details
Table 131. Johnson & Johnson Business Overview
Table 132. Johnson & Johnson Uterine Fibroids Product
Table 133. Johnson & Johnson Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 134. Johnson & Johnson Recent Development
Table 135. Novartis Company Details
Table 136. Novartis Business Overview
Table 137. Novartis Uterine Fibroids Product
Table 138. Novartis Revenue in Uterine Fibroids Business (2016-2021) & (US$ Million)
Table 139. Novartis Recent Development
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Uterine Fibroids Market Share by Type: 2020 VS 2027
Figure 2. Non-Hormonal Treatment Features
Figure 3. Hormonal Treatment Features
Figure 4. Global Uterine Fibroids Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Ambulatory Surgical Centers Case Studies
Figure 7. Diagnostic Centers Case Studies
Figure 8. Others Case Studies
Figure 9. Uterine Fibroids Report Years Considered
Figure 10. Global Uterine Fibroids Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Uterine Fibroids Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Uterine Fibroids Market Share by Regions: 2020 VS 2027
Figure 13. Global Uterine Fibroids Market Share by Regions (2022-2027)
Figure 14. Global Uterine Fibroids Market Share by Players in 2020
Figure 15. Global Top Uterine Fibroids Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Uterine Fibroids as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Uterine Fibroids Revenue in 2020
Figure 17. Global Uterine Fibroids Revenue Market Share by Type (2016-2021)
Figure 18. Global Uterine Fibroids Revenue Market Share by Type (2022-2027)
Figure 19. North America Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Uterine Fibroids Market Share by Type (2016-2027)
Figure 21. North America Uterine Fibroids Market Share by Application (2016-2027)
Figure 22. North America Uterine Fibroids Market Share by Country (2016-2027)
Figure 23. United States Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Uterine Fibroids Market Share by Type (2016-2027)
Figure 27. Europe Uterine Fibroids Market Share by Application (2016-2027)
Figure 28. Europe Uterine Fibroids Market Share by Country (2016-2027)
Figure 29. Germany Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Uterine Fibroids Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Uterine Fibroids Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Uterine Fibroids Market Share by Region (2016-2027)
Figure 39. China Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Uterine Fibroids Market Share by Type (2016-2027)
Figure 47. Latin America Uterine Fibroids Market Share by Application (2016-2027)
Figure 48. Latin America Uterine Fibroids Market Share by Country (2016-2027)
Figure 49. Mexico Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Uterine Fibroids Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Uterine Fibroids Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Uterine Fibroids Market Share by Country (2016-2027)
Figure 55. Turkey Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Uterine Fibroids Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Boston Scientific Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 59. Cooper Surgical Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 60. C.R. Bard Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 61. F. Hoffmann-La Roche Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 62. GE Healthcare Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 63. Karl Storz Endoscopy Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 64. Richard Wolf Medical Instruments Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 65. Siemens Medical Solutions Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 66. AbbVie Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 68. Bayer Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 69. Eli Lilly Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 70. GlaxoSmithKline Pharmaceuticals Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 71. Pfizer Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 72. Johnson & Johnson Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 73. Novartis Revenue Growth Rate in Uterine Fibroids Business (2016-2021)
Figure 74. Bottom-up and Top-down Approaches for This Report
Figure 75. Data Triangulation
Figure 76. Key Executives Interviewed
世界の急性・慢性異常子宮出血（AUB）市場規模・現状・予測（2021年-2027年） Abnormal uterine bleeding (AUB) may be acute or chronic and is defined as bleeding from the uterine corpus that is abnormal in regularity, volume, frequency, or duration and occurs in the absence of pregnancy. Market Analysis and Insights: Global Acute and Chronic Abnormal Uterine Bleeding Market Th…- 世界の子宮筋腫治療市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Uterine Fibroid Treatment Market The global Uterine Fibroid Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027. With industry-standard accuracy in analysis and high data integrity, th…
- 世界の尿抑制剤市場 2021：企業別、地域別、種類・用途別 The Uterine Depressor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, …
- 世界の子宮生検鉗子市場 2021：企業別、地域別、種類・用途別 The Uterine Biopsy Forceps market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulati…
- 世界の病院・外来診療センター市場規模・現状・予測（2021年-2027年） Hospitals and outpatient centers are medical facilities that provide diagnostic and medical treatment to patients with a wide range of medical conditions. Outpatient care centers offer medical care or treatment that does not require any overnight stay in a hospital or medical facility. Outpatient ca…